Entrada Therapeutics (TRDA) Amortizatization of Intangibles (2022 - 2025)

Entrada Therapeutics has reported Amortizatization of Intangibles over the past 4 years, most recently at $633000.0 for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at $633000.0 for Q4 2025, down 74.75% from a year ago — trailing twelve months through Dec 2025 was $3.7 million (down 63.36% YoY), and the annual figure for FY2025 was $3.7 million, down 63.36%.
  • Amortizatization of Intangibles for Q4 2025 was $633000.0 at Entrada Therapeutics, down from $739000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for TRDA hit a ceiling of $3.2 million in Q3 2024 and a floor of -$145000.0 in Q2 2022.
  • Median Amortizatization of Intangibles over the past 4 years was $1.1 million (2025), compared with a mean of $1.2 million.
  • Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 5687.5% in 2023 and later crashed 77.0% in 2025.
  • Entrada Therapeutics' Amortizatization of Intangibles stood at $104000.0 in 2022, then skyrocketed by 1822.12% to $2.0 million in 2023, then rose by 25.41% to $2.5 million in 2024, then crashed by 74.75% to $633000.0 in 2025.
  • The last three reported values for Amortizatization of Intangibles were $633000.0 (Q4 2025), $739000.0 (Q3 2025), and $961000.0 (Q2 2025) per Business Quant data.